Physician profile
Elliot S Marcus
NPI 1104881036
$2,182.34
in general payments reported to CMS, 2019-2025
4 companies · $85.77 in 2025
The $85.77 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $18.76 · 2022: $33.57 · 2023: $1,999 · 2024: $44.83 · 2025: $85.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $1,760 · Food and Beverage: $370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $1,760.00 |
| Food and Beverage | $370.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $2,051.74 | 2021-2023 | Exparel, Iovera |
| Merck Sharp & Dohme LLC | $96.01 | 2024-2025 | Bridion |
| Vertex Pharmaceuticals Incorporated | $21.39 | 2025 | |
| Atricure, INC. | $13.20 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elliot Marcus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.